Fidelity Investments’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
529,346
+42
+0% +$254 ﹤0.01% 2475
2025
Q4
$2.77M Sell
529,304
-1,982
-0.4% -$7.84K ﹤0.01% 2491
2025
Q3
$2.3M Sell
531,286
-37,853
-7% -$68.1K ﹤0.01% 2491
2025
Q2
$598K Buy
569,139
+566,479
+21,296% +$677K ﹤0.01% 2896
2025
Q1
$3.43K Buy
2,660
+1,672
+169% +$2.64K ﹤0.01% 4793
2024
Q4
$2.47K Sell
988
-1,747
-64% -$6.22K ﹤0.01% 4788
2024
Q3
$11.1K Buy
2,735
+427
+19% +$1.59K ﹤0.01% 4397
2024
Q2
$8.08K Sell
2,308
-654
-22% -$2.67K ﹤0.01% 4403
2024
Q1
$7.61K Buy
2,962
+1,769
+148% +$6.27K ﹤0.01% 4368
2023
Q4
$5.57K Buy
1,193
+528
+79% +$2.64K ﹤0.01% 4413
2023
Q3
$4.39K Buy
665
+382
+135% +$2.55K ﹤0.01% 4367
2023
Q2
$2.32K Buy
+283
New +$2.27K ﹤0.01% 4554

Other funds holding ZURA

Fidelity Investments's ZURA Position: Q1 2026 in Review

Fidelity Investments increased its Zura Bio (ZURA) stake by 0.01% in Q1 2026, buying an estimated $254 and bringing the position to 529,346 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Fidelity Investments first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Fidelity Investments held 529,346 shares of Zura Bio worth $3.15M as of Q1 2026.
  • Fidelity Investments bought 42 Zura Bio shares in Q1 2026, an estimated $254.
  • Zura Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2475 holding.
  • Fidelity Investments first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.